We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $268M
1-Year Est. Return 158.98%
This Fund
S&P 500
This Quarter Est. Return
+39.3%
1 Year Est. Return
+158.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$223M
AUM Growth
+$77.2M
Cap. Flow
+$48M
Cap. Flow %
21.55%
Top 10 Hldgs %
25.3%
Holding
464
New
223
Increased
67
Reduced
60
Closed
103

Sector Composition

1 Healthcare 52.36%
2 Technology 13.57%
3 Financials 11.27%
4 Communication Services 4.48%
5 Energy 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
26
Cogent Biosciences
COGT
$6.68B
$1.69M 0.76%
47,499
+25,013
+111% +$703K
ALHC icon
27
Alignment Healthcare
ALHC
$4.26B
$1.65M 0.74%
83,543
-43,386
-34% -$779K
APGE icon
28
CALL
Apogee Therapeutics
APGE
$10.1B
$1.64M 0.74%
566
+271
+92% +$17.1K
RBLX icon
29
Roblox
RBLX
$37B
$1.62M 0.73%
+20,000
New +$2.12M
EQX icon
30
Equinox Gold
EQX
$6.8B
$1.61M 0.72%
114,401
-27,992
-20% -$353K
UTHR icon
31
United Therapeutics
UTHR
$22.7B
$1.59M 0.71%
+3,267
New +$1.52M
MU icon
32
Micron Technology
MU
$959B
$1.58M 0.71%
+5,533
New +$1.27M
CAPR icon
33
Capricor Therapeutics
CAPR
$1.13B
$1.49M 0.67%
+51,481
New +$672K
RNAM
34
CALL
DELISTED
Avidity Biosciences
RNAM
$1.48M 0.66%
839
+381
+83% +$24.6K
GLNG icon
35
Golar LNG
GLNG
$5.05B
$1.46M 0.66%
+39,362
New +$1.5M
TGB
36
Trekor Metals
TGB
$2.48B
$1.46M 0.66%
258,329
+59,880
+30% +$282K
TRIP icon
37
TripAdvisor
TRIP
$1.7B
$1.46M 0.65%
+100,000
New +$1.52M
BBIO icon
38
BridgeBio Pharma
BBIO
$15.9B
$1.43M 0.64%
+18,696
New +$1.23M
SF
39
Stifel
SF
$11.8B
$1.41M 0.63%
16,841
+1,842
+12% +$147K
SAIL
40
SailPoint Inc
SAIL
$8.89B
$1.4M 0.63%
69,161
RVMD icon
41
Revolution Medicines
RVMD
$39.6B
$1.4M 0.63%
17,537
+3,910
+29% +$256K
SMWB icon
42
Similarweb
SMWB
$610M
$1.35M 0.61%
+180,000
New +$1.45M
SNPS icon
43
Synopsys
SNPS
$73.6B
$1.29M 0.58%
2,755
+1,457
+112% +$647K
HCSG icon
44
Healthcare Services Group
HCSG
$1.74B
$1.28M 0.57%
66,839
-80,528
-55% -$1.45M
RBRK icon
45
Rubrik
RBRK
$16.3B
$1.22M 0.55%
16,000
GLD icon
46
SPDR Gold Trust
GLD
$130B
$1.22M 0.55%
+3,068
New +$1.17M
NBN icon
47
Northeast Bank
NBN
$1.13B
$1.22M 0.55%
+11,691
New +$1.09M
VRTX icon
48
Vertex Pharmaceuticals
VRTX
$123B
$1.21M 0.54%
+2,666
New +$1.15M
VKTX icon
49
CALL
Viking Therapeutics
VKTX
$4.31B
$1.21M 0.54%
1,839
+911
+98% +$32.3K
CAH icon
50
Cardinal Health
CAH
$53.5B
$1.17M 0.53%
+5,695
New +$1.07M

Similar funds

Persistent Asset Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Persistent Asset Partners held 464 positions worth $223M, up 53% from $145M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Persistent Asset Partners deployed $48M of net new capital in Q4 2025, opening 223 new positions and adding to 67 existing holdings. Its largest new stake was Molina Healthcare: 51,285 shares worth $8.9M.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, up from 49% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was UnitedHealth, an estimated $3.15M trimmed.

  • Persistent Asset Partners's largest Q4 2025 buy was Molina Healthcare: 51,285 shares worth $8.9M.
  • Persistent Asset Partners added most to Elevance Health in Q4 2025, an estimated $5.15M increase.
  • Persistent Asset Partners's biggest Q4 2025 reduction was UnitedHealth, cutting an estimated $3.15M.
  • Persistent Asset Partners fully exited iShares 7-10 Year Treasury Bond ETF in Q4 2025, selling an estimated $4.82M.
  • Persistent Asset Partners's ten largest holdings make up 25% of its $223M portfolio in Q4 2025.
  • Persistent Asset Partners opened 223 new positions and closed 103 in Q4 2025.
  • Persistent Asset Partners's portfolio value rose 53% quarter-over-quarter to $223M.

Based on Persistent Asset Partners's 13F filing for Q4 2025, filed 17 Feb 2026.